Alto Neuroscience (ANRO) Reports FY25 Loss of $2.19/Share
Earnings Per Share (GAAP) $-2.19 vs $-0.41 est. Analyst sentiment remains constructive. Despite the loss, the analyst community maintains a ...
Tuesday, May 5, 2026
Tag: ANRO
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.